GE Healthcare UK interview (I): Using the early health model to transform healthcare delivery
This article was originally published in Clinica
Executive Summary
GE Healthcare has evolved over the last decade from a product-focused company into a provider of a range of diagnostic capabilities to address a disease or condition, frequently in consultation with national healthcare decision-makers. Now on the threshold of another major expansion, bringing divisions of Abbott Laboratories into the fold, and with its strengths in molecular medicine and a combined in vitro and in vivo approach to diagnostics, the group has a unique role to play in the way modern healthcare is delivered, Nigel Mason, president of GE Healthcare UK, told Ashley Yeo